SlideShare una empresa de Scribd logo
1 de 18
MEDICAL DEVICES
INTRODUCTION
 A medical device is an instrument, apparatus, in vitro
  reagent , implant or other similar or related article , which
  is intended for use in the diagnosis of disease or other
  condition ,or in the cure , mitigation , treatment , or
  prevention of disease or intended to affect the structure or
  any function of the body and which does not achieve any of
  its primary intended purposes through its chemical action
  within or on the body.
REGULATION IN INDIA
 In India medical devices are governed by CDSCO(Central
  Drugs Standard Control Organization) which is regulated
  by Directorate General of Health Services , Ministry of
  Health and Family Welfare , Government of India.
 CDSCO is the only government body which regulate the
  medical devices.
Cont….
 Many committees had been set up and given their opinion
 and recommendation , like the Mahelkar Committee –
 Central Drug Standard Control Organization.
 All these are now being taken into to form the Indian
 Medical Device regulatory Act (IMRDA).
IMRDA
 Indian Medical Devices Regulatory Act come in force
  December 31, 2009
 Inputs to be sent to Dr. B Hari Gopal , Adviser Department
  of Science and Technology, New Delhi .
IMRDA
 The composition of the committee is represented by:
 Central Government
 Eminent Jurist
 Two eminent medical practitioners
 Two eminent medical technologists
 Secretary General Quality council
IMRDA ESSENTIAL PRINCIPLES
 Should not compromise health and safety
 Design and manufacture of devices must conform with
  safety principles
 Long term safety should be ensured
 Benefits of the devices must outweigh any side effects
 Medical devices should be useful for the intended purpose
IMRDA OBJECTIVES
 Provide notification of essential principles
 Provide for risk based classification of devices
 Notify standards and guidelines
 Provide mechanism of conformity
 Provide a post market surveillance system
 Provide for enforcement
IMRDA The regulation
Will issue
    Design and manufacturing requirements
    Performance evaluation
    Demonstration of device standards , testing and
     compliance
    Regulation of post marketing follow up
    Regulation of recalls
    Legislate and punishment for non compliance
    Principle of safety
IMRDA classification
 Class A– Devices involving low risk levels


 Class B– devices involving low to medium risk


 Class C – Devices involving moderate to high risk


 Class D– Devices involving high risk.
The Drug and Cosmetic Act
 Covers the pharmaceutical products and cosmetic.
 Added medical devices as early as1992(syringes , needles
  , etc.)
 As per the latest list of regulated medical devices , issued
  on the 20/04/2010 , listed following devices:
 Disposable hypodermic needles
 Disposable hypodermic syringes
 Disposable perfusion sets
 In vitro diagnostic devices for HIV, HbsAg.
 Cardiac stents
 Catheters
 Intra ocular lenses
 Drug eluting stents
 i.v.cannulae
 Bone cement
 Heart valve
 Scalp vein sets
 Orthopedic implant
 Internal prosthetic replacement
The Drug and Cosmetic Act
 Additionally following products are regulated as ‘Drugs’
  under Drugs & Cosmetics Act & Rules there under:-
 Blood grouping sera
 Ligatures , sutures & staplers
 Intra uterine devices
 Condoms
 Tubal rings
 Surgical dressings
 Umbilical cord
 Blood/blood related products
SIGNIFICANCE OF MEDICAL DEVICES
 The medical development in terms of drugs and devices
  has brought about the robust change in the life of the
  people. Medical devices have extended the ability of
  physicians to diagnose and treat diseases, making great
  contributions to health and quality of life.
 Like medicines and other health technologies, they are
  essential for patient care at the bedside, at the rural health
  clinics or at the large, specialized hospitals.
ROLE OF PHARMACIST IN REGULATION ON
USE OF MEDICAL DEVICES
 Pharmacist should:
 have proper understanding of medical device safety, risk
 involved, the degree of invasiveness, duration of
 contact, the body system affected, and local versus
 systemic effects.
 be actively involved in the regulation of effectiveness and
 performance of medical device.
LATEST DEVELOPMENT IN MEDICAL
       DEVICE REGULATION
 There are only14 medical devices regulated by Drug Controller
  General of India (DCGI).
 Currently, a number of specific medical devices are regulated as drugs
  and fall under India’s Drugs and Cosmetics Act (DCA).
 Since 2008, both the Indian Department of Science and Technology
  and the Ministry of Health have sought to completely restructure the
  regulations for medical devices.
 Department of Science and Technology : proposed creation of a
  Medical Devices Regulatory Authority that would operate similar to a
  division within the CDSCO.
 Ministry of Health: proposed revision of the DCA that would create a
  Central Drug Authority to function similarly to the U.S. FDA.
 The CDSCO is continuing to entrench its own medical device
  regulation standards. In June 2009, it seemed as if the CDSCO would
  begin its own form of medical device regulations.
 CDSCO: released schedule M-3 which provided an official definition
  for medical devices, outlined a four level medical device risk
  classification scheme, created a body within the CDSCO to regulate
  medical devices in India.
 Ministry of Health and Family Welfare, Government of India, with
  WHO funding, initiated a country wide National Pharmacovigilance
  Program.
 Central Drugs Standard Control Organization (CDSCO), New
  Delhi, coordinates the program. The Honorable Minister of Health, Dr.
  Anbumani Ramadass at New Delhi, officially launched the program
  on November 23, 2004.
Medical device

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Regulatory requirement and approval procedure for medical devices
Regulatory requirement and approval procedure for medical devicesRegulatory requirement and approval procedure for medical devices
Regulatory requirement and approval procedure for medical devices
 
Regulatory authority of japan
Regulatory authority of japanRegulatory authority of japan
Regulatory authority of japan
 
Introduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairsIntroduction to Pharma regulatory affairs
Introduction to Pharma regulatory affairs
 
History of medical devices
History of medical devicesHistory of medical devices
History of medical devices
 
Drug approval process in japan
Drug approval process in japanDrug approval process in japan
Drug approval process in japan
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and grouping
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 
USFDA
USFDAUSFDA
USFDA
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
 
Medical Device Regulation
Medical Device RegulationMedical Device Regulation
Medical Device Regulation
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
 
Cdsco ppt
Cdsco pptCdsco ppt
Cdsco ppt
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
Regulation for medical devices
Regulation for medical devicesRegulation for medical devices
Regulation for medical devices
 
Medical device regulation US, European Union and India
Medical device regulation  US, European Union and IndiaMedical device regulation  US, European Union and India
Medical device regulation US, European Union and India
 
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, DefinitionsMedical Devices Regulation (MDR)  2017/745 - Part I Purpose, Scope, Definitions
Medical Devices Regulation (MDR) 2017/745 - Part I Purpose, Scope, Definitions
 
medical device regulatory approval in USA
medical device regulatory approval in USAmedical device regulatory approval in USA
medical device regulatory approval in USA
 
China\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory ProcessChina\'s Medical Device Regulatory Process
China\'s Medical Device Regulatory Process
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 

Destacado (11)

Pollution control acts
Pollution control actsPollution control acts
Pollution control acts
 
Biosafety guidelines
Biosafety guidelinesBiosafety guidelines
Biosafety guidelines
 
Environment Act, 1986
Environment Act, 1986Environment Act, 1986
Environment Act, 1986
 
Schedule y
Schedule ySchedule y
Schedule y
 
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTS
 
Geographical indicators
Geographical indicatorsGeographical indicators
Geographical indicators
 
Schedule M in pharmaceutical industries
Schedule M in pharmaceutical industries Schedule M in pharmaceutical industries
Schedule M in pharmaceutical industries
 
Geographical indications ppt
Geographical indications pptGeographical indications ppt
Geographical indications ppt
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
Factory act(1948)
Factory act(1948)Factory act(1948)
Factory act(1948)
 
Icmr Code
Icmr CodeIcmr Code
Icmr Code
 

Similar a Medical device

Reg summary
Reg summaryReg summary
Reg summary
ruyang89
 
regulation for combination product and medical devices
regulation for combination product and medical devicesregulation for combination product and medical devices
regulation for combination product and medical devices
SNEHADAS123
 
Medical Devices
Medical DevicesMedical Devices
Medical Devices
pviral24
 

Similar a Medical device (20)

Medical Device Act.pptx
Medical Device Act.pptxMedical Device Act.pptx
Medical Device Act.pptx
 
Medical Device Act.pptx
Medical Device Act.pptxMedical Device Act.pptx
Medical Device Act.pptx
 
Combinational products & medical devices
Combinational products & medical devicesCombinational products & medical devices
Combinational products & medical devices
 
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICESREGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
REGULATIONS FOR COMBINATION PRODUCTS AND MEDICAL DEVICES
 
Medical device Industry 2015
Medical device Industry 2015Medical device Industry 2015
Medical device Industry 2015
 
Reg summary
Reg summaryReg summary
Reg summary
 
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptxNEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
 
2. regulations overview
2. regulations overview2. regulations overview
2. regulations overview
 
Regulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical researchRegulations, guidelines & ethics in clinical research
Regulations, guidelines & ethics in clinical research
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
 
Medical Devices , regulations and e health solutions
Medical Devices , regulations and e health solutionsMedical Devices , regulations and e health solutions
Medical Devices , regulations and e health solutions
 
CDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdfCDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdf
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
 
regulation for combination product and medical devices
regulation for combination product and medical devicesregulation for combination product and medical devices
regulation for combination product and medical devices
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
 
suvarnsing pardeshi roll no-69.pptx
suvarnsing pardeshi roll no-69.pptxsuvarnsing pardeshi roll no-69.pptx
suvarnsing pardeshi roll no-69.pptx
 
Medical Devices
Medical DevicesMedical Devices
Medical Devices
 
Layout of starting the medical device business in India.
Layout of starting the medical device business in India.Layout of starting the medical device business in India.
Layout of starting the medical device business in India.
 
Medical Equipment 2023 4th YR(1).pdf
Medical Equipment 2023 4th YR(1).pdfMedical Equipment 2023 4th YR(1).pdf
Medical Equipment 2023 4th YR(1).pdf
 

Más de bdvfgbdhg

Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
bdvfgbdhg
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......sn
bdvfgbdhg
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in india
bdvfgbdhg
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european union
bdvfgbdhg
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)
bdvfgbdhg
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisation
bdvfgbdhg
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changes
bdvfgbdhg
 
Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2
bdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
bdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
bdvfgbdhg
 

Más de bdvfgbdhg (12)

Snda
SndaSnda
Snda
 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......sn
 
Nppa
NppaNppa
Nppa
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in india
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european union
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisation
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changes
 
Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2Drug abuse & control act 1970 ppt dra2
Drug abuse & control act 1970 ppt dra2
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 

Medical device

  • 2. INTRODUCTION  A medical device is an instrument, apparatus, in vitro reagent , implant or other similar or related article , which is intended for use in the diagnosis of disease or other condition ,or in the cure , mitigation , treatment , or prevention of disease or intended to affect the structure or any function of the body and which does not achieve any of its primary intended purposes through its chemical action within or on the body.
  • 3. REGULATION IN INDIA  In India medical devices are governed by CDSCO(Central Drugs Standard Control Organization) which is regulated by Directorate General of Health Services , Ministry of Health and Family Welfare , Government of India.  CDSCO is the only government body which regulate the medical devices.
  • 4. Cont….  Many committees had been set up and given their opinion and recommendation , like the Mahelkar Committee – Central Drug Standard Control Organization.  All these are now being taken into to form the Indian Medical Device regulatory Act (IMRDA).
  • 5. IMRDA  Indian Medical Devices Regulatory Act come in force December 31, 2009  Inputs to be sent to Dr. B Hari Gopal , Adviser Department of Science and Technology, New Delhi .
  • 6. IMRDA  The composition of the committee is represented by:  Central Government  Eminent Jurist  Two eminent medical practitioners  Two eminent medical technologists  Secretary General Quality council
  • 7. IMRDA ESSENTIAL PRINCIPLES  Should not compromise health and safety  Design and manufacture of devices must conform with safety principles  Long term safety should be ensured  Benefits of the devices must outweigh any side effects  Medical devices should be useful for the intended purpose
  • 8. IMRDA OBJECTIVES  Provide notification of essential principles  Provide for risk based classification of devices  Notify standards and guidelines  Provide mechanism of conformity  Provide a post market surveillance system  Provide for enforcement
  • 9. IMRDA The regulation Will issue Design and manufacturing requirements Performance evaluation Demonstration of device standards , testing and compliance Regulation of post marketing follow up Regulation of recalls Legislate and punishment for non compliance Principle of safety
  • 10. IMRDA classification  Class A– Devices involving low risk levels  Class B– devices involving low to medium risk  Class C – Devices involving moderate to high risk  Class D– Devices involving high risk.
  • 11. The Drug and Cosmetic Act  Covers the pharmaceutical products and cosmetic.  Added medical devices as early as1992(syringes , needles , etc.)  As per the latest list of regulated medical devices , issued on the 20/04/2010 , listed following devices:  Disposable hypodermic needles  Disposable hypodermic syringes  Disposable perfusion sets  In vitro diagnostic devices for HIV, HbsAg.  Cardiac stents
  • 12.  Catheters  Intra ocular lenses  Drug eluting stents  i.v.cannulae  Bone cement  Heart valve  Scalp vein sets  Orthopedic implant  Internal prosthetic replacement
  • 13. The Drug and Cosmetic Act  Additionally following products are regulated as ‘Drugs’ under Drugs & Cosmetics Act & Rules there under:-  Blood grouping sera  Ligatures , sutures & staplers  Intra uterine devices  Condoms  Tubal rings  Surgical dressings  Umbilical cord  Blood/blood related products
  • 14. SIGNIFICANCE OF MEDICAL DEVICES  The medical development in terms of drugs and devices has brought about the robust change in the life of the people. Medical devices have extended the ability of physicians to diagnose and treat diseases, making great contributions to health and quality of life.  Like medicines and other health technologies, they are essential for patient care at the bedside, at the rural health clinics or at the large, specialized hospitals.
  • 15. ROLE OF PHARMACIST IN REGULATION ON USE OF MEDICAL DEVICES  Pharmacist should:  have proper understanding of medical device safety, risk involved, the degree of invasiveness, duration of contact, the body system affected, and local versus systemic effects.  be actively involved in the regulation of effectiveness and performance of medical device.
  • 16. LATEST DEVELOPMENT IN MEDICAL DEVICE REGULATION  There are only14 medical devices regulated by Drug Controller General of India (DCGI).  Currently, a number of specific medical devices are regulated as drugs and fall under India’s Drugs and Cosmetics Act (DCA).  Since 2008, both the Indian Department of Science and Technology and the Ministry of Health have sought to completely restructure the regulations for medical devices.  Department of Science and Technology : proposed creation of a Medical Devices Regulatory Authority that would operate similar to a division within the CDSCO.  Ministry of Health: proposed revision of the DCA that would create a Central Drug Authority to function similarly to the U.S. FDA.
  • 17.  The CDSCO is continuing to entrench its own medical device regulation standards. In June 2009, it seemed as if the CDSCO would begin its own form of medical device regulations.  CDSCO: released schedule M-3 which provided an official definition for medical devices, outlined a four level medical device risk classification scheme, created a body within the CDSCO to regulate medical devices in India.  Ministry of Health and Family Welfare, Government of India, with WHO funding, initiated a country wide National Pharmacovigilance Program.  Central Drugs Standard Control Organization (CDSCO), New Delhi, coordinates the program. The Honorable Minister of Health, Dr. Anbumani Ramadass at New Delhi, officially launched the program on November 23, 2004.